Biogen Market Sentiment

Biogen Inc

BIIBNASDAQ

$244.05

-8.68-3.43%

Últ. Act.: Oct 28, 4:39 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Ganancias: Los beneficios de Q3 2026 se han publicado hoy antes de la apertura del mercado

Conferencia telefónica: La conferencia telefónica de hoy comenzó hace 16 horas

Haz clic para ver el webcast

Biogen Market Sentiment - Benzinga

Biogen Market Sentiment

Market sentiment signals for Biogen (BIIB): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 4.5% short float

Options Flow▼ 2.64 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

30 analysts

Options Flow (P/C)

2.64

More puts — Bearish

3,027 calls · 7,980 puts

Avg Consensus PT

$236

-3.1%

Highest Price Target

$310

+27.0%

Wells Fargo

Lowest Price Target

$157

-35.7%

Bernstein

Short Interest

4.5%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 28, 2026	Barclays	Emily Field—	-5.8%	$200 → $230	Maintained	Equal-Weight
Oct 22, 2026	B of A Securities	Jason Zemansky—	-0.0%	$219 → $244	Maintained	Neutral
Oct 21, 2026	TD Cowen	Phil Nadeau—	+2.4%	$225 → $250	Maintained	Buy
Oct 20, 2026	Wells Fargo	Mohit Bansal—	+27.0%	$250 → $310	Maintained	Overweight
Oct 12, 2026	JP Morgan	Chris Schott—	+22.9%	$210 → $300	Upgrade	Neutral→Overweight
Oct 9, 2026	UBS	Michael Yee—	+10.6%	$240 → $270	Maintained	Buy
Oct 8, 2026	RBC Capital	Brian Abrahams—	+4.9%	$260 → $256	Maintained	Outperform
Sep 10, 2026	HSBC	Rajesh Kumar—	-28.3%	$165 → $175	Maintained	Reduce
Sep 3, 2026	Piper Sandler	David Amsellem—	+0.4%	$225 → $245	Maintained	Overweight
Aug 25, 2026	RBC Capital	Brian Abrahams—	+6.5%	$240 → $260	Maintained	Outperform
Aug 13, 2026	Wolfe Research	Alexandria Hammond—	+22.9%	$300	Upgrade	Peer Perform→Outperform
Aug 4, 2026	Mizuho	Salim Syed—	-1.2%	$221 → $241	Maintained	Outperform
Aug 3, 2026	Citigroup	Geoff Meacham—	-11.9%	$200 → $215	Maintained	Neutral
Jul 30, 2026	UBS	Michael Yee—	-1.7%	$225 → $240	Maintained	Buy
Jul 30, 2026	HC Wainwright & Co.	Andrew S. Fein—	+2.8%	$237 → $251	Maintained	Buy
Jul 30, 2026	Morgan Stanley	Matthew Harrison—	-5.3%	$222 → $231	Maintained	Equal-Weight
Jul 30, 2026	RBC Capital	Brian Abrahams—	-1.7%	$242 → $240	Maintained	Outperform
Jul 30, 2026	Canaccord Genuity	Sumant Kulkarni—	+1.6%	$245 → $248	Maintained	Buy
Jul 30, 2026	TD Cowen	Phil Nadeau—	-7.8%	$215 → $225	Maintained	Buy
Jul 30, 2026	Wedbush	Laura Chico—	-11.9%	$201 → $215	Maintained	Neutral
Jul 29, 2026	Barclays	Emily Field—	-18.0%	$185 → $200	Maintained	Equal-Weight
Jul 21, 2026	Guggenheim	Brad Canino—	+14.7%	$260 → $280	Maintained	Buy
Jul 21, 2026	B of A Securities	Jason Zemansky—	-11.9%	$217 → $215	Maintained	Neutral
Jul 13, 2026	Truist Securities	Danielle Brill—	-3.7%	$190 → $235	Upgrade	Hold→Buy
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	-9.0%	$224 → $222	Maintained	Equal-Weight